Stephen Kanes
CIK 1612859 · View on SEC EDGAR ↗
First SEC filing: June 24, 2026 · Latest: June 24, 2026
On this page
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 24, 2026 | CNTA | D | 500,000 | — | — | 0 Direct | -100.00% | Disposed | |
| June 24, 2026 | CNTA | D | 120,000 | — | — | 0 Direct | -100.00% | Disposed |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 24, 2026 | CNTA | Share Option (right to buy) | Ordinary Shares [F1] (500,000) | $16.90 | Feb. 3, 2035 | 500,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CIK 1847903
M.D., Ph.D. (3)Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $519,034 | $283,500 | — | $5,996,146 | — | — | $14,000 | $6,812,680 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.